Difference by sex but not by race/ethnicity in the visceral adipose tissue-depressive symptoms association: The Multi-Ethnic Study of Atherosclerosis

Psychoneuroendocrinology

Volumn 47, Issue , 2014, Pages 78-87

  Remigio Baker, Rosemay A ^a,b   Allison, Matthew A ^b   Schreiner, Pamela J ^c   Szklo, Moyses ^a   Crum, Rosa M ^a,d   Leoutsakos, Jeannie Marie ^a,d   Franco, Manuel ^a   Carnethon, Mercedes R ^e   Nettleton, Jennifer A ^f   Mujahid, Mahasin S ^g   Diez Roux, Ana V ^h   Jensky, Nicole ^b   Golden, Sherita H ^a,d  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antidepressant use; Elevated depressive symptoms; Race ethnicity; Sex; Visceral adipose tissue; Visceral fat mass

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BLACK PERSON; BODY MASS; CAUCASIAN; CHINESE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; ETHNIC DIFFERENCE; FEMALE; HEALTH BEHAVIOR; HISPANIC; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SCORING SYSTEM; SEX DIFFERENCE; ABDOMINAL OBESITY; ANATOMY AND HISTOLOGY; ANCESTRY GROUP; ATHEROSCLEROSIS; BODY COMPOSITION; COMPLICATION; CROSS-SECTIONAL STUDY; ETHNIC GROUP; ETHNOLOGY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BODY COMPOSITION; BODY MASS INDEX; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DEPRESSION; ETHNIC GROUPS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; SEX FACTORS; WAIST CIRCUMFERENCE;

EID: 84903692087     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.05.004     Document Type: Article

References (70)

1. Addis M.E., Mahalik J.R. Men, masculinity, and the contexts of help seeking. Am. Psychol. 2003, 58:5-14.
2. Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants. Horm. Behav. 2006, 50:534-538.
3. Aneshensel C.S., Clark V.A., Frerichs R.R. Race, ethnicity, and depression: a confirmatory analysis. J. Pers. Soc. Psychol. 1983, 44:385-398.
4. Beekman A.T., Deeg D.J., Van Limbeek J., Braam A.W., De Vries M.A., Van Tilburg W. Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol. Med. 1997, 27:231-235.
5. Bild D.E., Bluemke D.A., Burke G.L., Detrano R., Diez Roux A.V., Folsom A.R., Greenland P., Jacobs D.R., Kronmal R., Liu K., Nelson J.C., O'Leary D.O., Saad M.F., Shea S., Szklo M., Tracy R.P. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am. J. Epidemiol. 2002, 156:871-881.
6. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes. Rev. 2001, 2:73-86.
7. Bjorntorp P., Rosmond R. Neuroendocrine abnormalities in visceral obesity. Int. J. Obes. Relat. Metab. Disord. 2000, 24:S80-S85.
8. Bronnegard M., Arner P., Hellstrom L., Akner G., Gustafsson J.A. Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue. Endocrinology 1990, 127:1689-1696.
9. Capuron L., Ravaud A., Gualde N., Bosmans E., Dantzer R., Maes M., Neveu P.J. Association between immune activation and early depressive symptoms in cancer patients treatment with interleukin-2-based therapy. Psychoneuroendocrinology 2001, 26:797-808.
10. Cheung C., Bagley C. Validating an American scale in Hong Kong: The Center for Epidemiological Studies Depression Scale (CES-D). J. Psychol. 1998, 132:169-186.
11. Chrousos G., Gold P. The concepts of stress and stress system disorders: overview of physical and behavioral homeostasis. JAMA 1992, 267:1244-1252.
12. Cushman M., Legault C., Barrett-Connor E., Stefanick M.L., Kessler C., Judd H.L., Sakkinen P.A., Tracy R.P. Effect of postmenopausal hormones on inflammation-sensitive proteins. Circulation 1999, 100:717-722.
13. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
14. Demerath E.W., Sun S.S., Rogers N., Lee M., Reed D., Choh A.C., Couch W., Czerwinski S.A., Chumlea W.C., Siervogel R.M., Towne B. Anatomical patterning of visceral adipose tissue: race, sex, and age variation. Obesity 2007, 15:2984-2993.
15. Deuschle M., Weber B., Colla M., Depner M., Hippisley-Cox J. Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress 1998, 2:281-287.
16. Earle T., Linden W., Weinberg J. Differential effects of harassment on cardiovascular and salivary cortisol stress reactivity and recovery in women and men. J. Psychosom. Res. 1999, 46:125-141.
17. Ehret M., Sobieraj D.M. Prevention of interferon-alpha-associated depression with antidepressant medications in patients with hepatitis C virus: a systematic review and meta-analysis. Int. J. Clin. Pract. 2014, 68:255-261.
18. Everson-Rose S.A., Lewis T.T., Karavolos K., Dugan S.A., Wesley D., Powell L.H. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom. Med. 2009, 71:410-416.
19. Frankenhaeuser M., von Wright M.R., Collins A., Von Wright J., Sedvall G., Swahn C.G. Sex differences in psychoneuroendocrine reactions to examination stress. Psychosom. Med. 1978, 40:334-343.
20. Genuth S., Alberti K., Bennett P., Buse J., Defronzo R., Kahn R., Kitzmiller J., Knowler W., Lebovitz H., Lernmark A., Nathan D., Palmer J., Rizza R., Saudek C., Shaw J., Steffes M., Stern M., Tuomilehto J., Simmet P., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
21. Georg Hsu L.K., Wan Y.M., Chang H., Summergrad P., Tsang B.Y., Chen H. Stigma of depression is more severe in Chinese Americans than Caucasian Americans. Psychiatry 2008, 71:210-218.
22. Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up on the Whitehall II STudy. Psychol. Med. 2009, 39:413-423.
23. Golden S.H., Lee H.B., Schreiner P.J., Diez Roux A.V., Fitzpatrick A.L., Szklo M., Lyketsos C. Depression and type 2 diabetes mellitus: the Multiethnic Study of Atherosclerosis. Psychosom. Med. 2007, 69:529-536.
24. Golding J.M., Burnam A. Immigration, stress, and depressive symptoms in a Mexican-American community. J. Nerv. Ment. Dis. 1990, 178:161-171.
25. Gonzalez H.M., Croghan T., West B., Williams D., Nesse R., Tarraf W., Taylor R., Hinton L., Neighbors H., Jackson J. Antidepressant use in Black and White populations in the United States. Psychiatr. Serv. 2008, 59:1131-1138.
26. Gonzalez H.M., Tarraf W., West B., Croghan T., Bowen M., Cao Z., Alegria M. Antidepressant use in a nationally representative sample of community-dwelling US Latinos with and without depressive and anxiety disorders. Depress. Anxiety 2009, 26:674-681.
27. Gonzalez H.M., Tarraf W., West B.T., Chan D., Miranda P.Y., Leong F.T. Antidepressant use among Asians in the United States. Depress. Anxiety 2010, 27:46-55.
28. Greggersen W., Rudolf S., Fassbinder E., Dibbelt L., Stoeckelhuber B.M., Hohagen F., Oltmanns K.M., Kahl K.G., Schweiger U. Major depression, borderline personality disorder, and visceral fat content in women. Eur. Arch. Psychiatry Clin. Neurosci. 2011, 261:551-557.
29. Gimeno D., Kivimaki M., Brunner E.J., Elovainio M., De Vogli R., Steptoe A., Kumari M., Lowe G.D., Rumley A., Marmot M.G., Ferrie J.E. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II Study. Psychol. Med. 2009, 39:413-423.
30. Griffiths K.M., Christensen H., Jorm A.F. Predictors of depression stigma. BMC Psychiatry 2008, 8:1-12.
31. Haringsma R., Engels G.I., Beekman A.T.F., Spinhoven P. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int. J. Geriatr. Psychiatry 2004, 19:558-563.
32. Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch. Intern. Med. 1997, 157:2413-2466.
33. Kahl K.G., Bester M., Greggersen W., Rudolf S., Dibbelt L., Stoeckelhuber B.M., Gehl H.B., Sipos V., Hohagen F., Schweiger U. Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom. Med. 2005, 67:407-412.
34. Kalynchuk L.E., Gregus A., Boundreau D., Perrot-Sinal T.S. Corticosterone increases depression-like behavior, with some effects on predator odor-induced defensive behavior, in male and female rats. Behav. Neurosci. 2004, 118:1365-1377.
35. Kendler K.S., Myers J., Prescott C.A. Sex differences in the relationship between social support and risk for major depression: a longitudinal study of opposite-sex twin pairs. Am. J. Psychiatry 2005, 162:250-256.
36. Kent S., Bluthe R.M., Kelley K., Dantzer W.R. Sickness behavior as a new target for drug development. Trends Pharmacol. Sci. 1992, 13:24-28.
37. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
38. Lee E.S., Kim Y.H., Beck S.-H., Lee S., Oh S.W. Depressive mood and abdominal fat distribution in overweight premenopausal women. Obes. Res. 2005, 13:320-325.
39. Li Z., Hicks M.H.-R. The CES-D in Chinese American women: construct validity, diagnostic validity for major depression and cultural response bias. Psychiatry Res. 2010, 28:227-232.
40. Lin H.-C., Erickson S.R., Balkrishnan R. Physician prescribing patterns of innovative antidepressants in the United States: the case of MDD patients 1993-2007. Int. J. Psychiatry Med. 2011, 42:353-368.
41. Logan J., Barksdale D. Allostasis and allostatic load: expanding the discourse on stress and cardiovascular disease. J. Clin. Nurs. 2008, 17:201-208.
42. Lovejoy J. The influence of sex hormones on obesity across the female life span. J. Womens Health 1998, 7:1247-1256.
43. Ludescher B., Machann J., Eschweiler G.W., Thamer C., Maenz C., Hipp A., Claussen C.D., Schick F. Active depression is associated with regional adiposity in the upper abdomen and the neck. Int. J. Psychiatry Med. 2011, 41:271-280.
44. Ludescher B., Najib A., Baar S., Machann J., Schick F., Buchkremer G., Claussen C.D., Eschweiler G.W. Increase of visceral fat and adrenal gland volume in women with depression: preliminary results of a morphometric MRI study. Int. J. Psychiatry Med. 2008, 38:229-240.
45. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W.J.H., Zitman F.G. Overweight, obesity and depression: a systematic review and meta-analysis of longitudinal studies. Arch. Gen. Psychiatry 2010, 67:220-229.
46. Maciejewski P.K., Prigerson H.G., Mazure C.M. Sex differences in event-related risk for major depression. Psychol. Med. 2001, 31:593-604.
47. Matthews K.L., Schott L.L., Bromberger J.T., Cyranowski J.M., Everson-Rose S.A., Sowers M. Are there bi-directional associations between depressive symptoms and C-reactive protein in mid-life women?. Brain Behav. Immun. 2010, 24:96-101.
48. Milaneschi Y., Simonsick E.M., Vogelzangs N., Strotmeyer E.S., Yaffe K., Harris T.B., Tolea M.I., Ferrucci L., Penninx B.W. Leptin, abdominal obesity and onset of depression in older men and women. J. Clin. Psychiatry 2012, 73:1205-1211.
49. Murabito J.M., Massaro J.M., Clifford B., Hoffmann U., Fox C.S. Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity 2013, 21:1713-1719.
50. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch. Gen. Psychiatry 1998, 55:580-592.
51. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alpha. N. Engl. J. Med. 2001, 344:961-966.
52. National Institute of Health Surmontil (Tripramine Maleate) Capsule 2007, retrieved from http://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=8820 (accessed 27.4.12).
53. Ohlson L., Larsson B., Svardsudd K., Welin L., Eriksson H., Wilhelmsen L., Bjorntorp P., Tibblin G. The influence of body fat distribution on the incidence of diabetes mellitus, 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985, 34:1055-1058.
54. Pederson S.B., Jonler M., Richelsen B. Characterization of regional and gender differences in glucocorticoid receptors and lipoprotein lipase activity in human adipose tissue. J. Clin. Endocrinol. Metab. 1994, 78:1354-1359.
55. Piccinelli M., Wilkinson G. Gender differences in depression. Critical review. Br. J. Psychiatry 2000, 177:486-492.
56. Radloff L., Locke B. Center for Epidemiologic Studies Depression Scale (CES-D). Handbook of Psychiatric Measures 2000, 523-526. American Psychiatric Publishing, Inc., Washington, DC. 1st edn. A.J. Rush, M.B. First, D. Blacker (Eds.).
57. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1:1385-1401.
58. Rexrode K.M., Carey V.J., Hennekens C.H., Walters E.E., Colditz G.A., Stampfer M.J., Willett W.C., Manson J.E. Abdominal adiposity and coronary heart disease in women. JAMA 1998, 280:1843-1848.
59. Roberts R.E. Reliability of the CES-D scale in different ethnic contexts. Psychiatry Res. 1980, 2:125-134.
60. Roelfsema F., van den Berg G., Frölich M., Veldhuis J.D., van Eijk A., Buurman M.M., Etman B.H. Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J. Clin. Endocrinol. Metab. 1993, 77:234-240.
61. Scheibel R.S., Valentine A.D., O'Brien S., Meyeres C.A. Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J. Neuropsychiatry Clin. Neurosci. 2004, 16:185-191.
62. Serretti A., Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J. Clin. Psychiatry 2010, 71:1259-1272.
63. Strickland T.L., Stein R., Lin K.-M., Risby E., Fong R. The pharmacologic treatment of anxiety and depression in African Americans: considerations for the general practitioner. Arch. Fam. Med. 1997, 6:371-375.
64. Sussman N., Ginsberg D., Bikoff J. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. J. Clin. Psychiatry 2001, 62:256-260.
65. Thakore J.H., Richards P.J., Reznek R.H., Martin A., Dinan T.G. Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiatry 1997, 41:1140-1142.
66. Vogelzangs N., Kritchevsky S.B., Beekman A.T.F., Brenes G.A., Newman A.B., Satterfield S., Yaffe K., Harris T.B., Penninx B.W.J.H. Obesity and onset of significant depressive symptoms: results from a community-based cohort of older men and women. J. Clin. Psychiatry 2010, 71:391-399.
67. Vogelzangs N., Kritchevsky S.B., Beekman A.T.F., Newman A.B., Satterfield S., Simonsick E.M., Yaffe K., Harris T.B., Penninx B.W.J.H. Depressive symptoms and change in abdominal obesity in older persons. Arch. Gen. Psychiatry 2008, 65:1386-1393.
68. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., Heuser I. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosom. Med. 2002, 64:274-277.
69. Weber-Hamann B., Werner M., Hentschel F., Bindeballe N., Lederbogen F., Deuschle M., Heuser I. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006, 31:347-354.
70. Zich J., Attkinsson C., Grenfield T. Screening for depression in primary care clinics: the CES-D and the BDI. Int. J. Psychiatry Med. 1990, 20:259-277.